The Online Investor

Slideshow Stock Splits

By The Online Investor Staff, updated Mon., Oct. 3, 1:44 PM

Slide #7. Nabriva Therapeutics plc (NASDAQ:NBRV) 1 for 25 Reverse Split

Announced: 9/15/2022
Stock Split: 1 for 25
Record Date: 9/15/2022
Pay Date: 9/16/2022
NBRV Optionable?: Yes

Nabriva Therapeutics is a holding company. Through its subsidiaries, Co. is a biopharmaceutical company engaged in the research, development and commercialization of anti-infective agents to treat serious infections. Co. has approval from the U.S. Food and Drug Administration for XENLETA for the treatment of adults with community-acquired bacterial pneumonia. XENLETA is an oral and intravenous treatment in the pleuromutilin class of antibiotics available for the systematic administration in humans. Co.'s CONTEPO is a potentially epoxide antibiotic for intravenous use in the U.S. for complicated urinary tract infections. Co. may develop XENLETA and CONTEPO for additional indications.
NBRV Detailed Information Page & Split History »

Company Name: 
Nabriva Therapeutics Plc
Website: 
www.nabriva.com
Sector: 
Drugs & Pharmaceuticals

Open the NBRV Page at The Online Investor (in a new window) »

Quotes delayed 20 minutes

Email EnvelopeFree NBRV Email Alerts:
Get SEC Filing Alerts
Get Dividend Alerts

Buy (2.67 out of 4)
100th percentile
(ranked higher than approx. 100% of all stocks covered)
Based on Zacks ABR data;
powered by Xignite

Stock Splits Page | www.TheOnlineInvestor.com

Copyright © 1998 - 2022, All Rights Reserved
Nothing in The Online Investor is intended to be investment advice, nor does it represent the opinion of, counsel from, or recommendations by BNK Invest Inc. or any of its affiliates, subsidiaries or partners. None of the information contained herein constitutes a recommendation that any particular security, portfolio, transaction, or investment strategy is suitable for any specific person. All viewers agree that under no circumstances will BNK Invest, Inc,. its subsidiaries, partners, officers, employees, affiliates, or agents be held liable for any loss or damage caused by your reliance on information obtained. By visiting, using or viewing this site, you agree to the following Full Disclaimer & Terms of Use and Privacy Policy. Video widget and stock market videos powered by Market News Video. Quote data delayed at least 20 minutes; data powered by Ticker Technologies, and Mergent. Contact The Online Investor; Meet Our Editorial Staff.